These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 562238)

  • 41. Comparative study of immunomodulatory properties of muramyl peptides on immune system cells of young and old mice.
    Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):149-63. PubMed ID: 8077604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs.
    Sharma SD; Tsai V; Krahenbuhl JL; Remington JS
    Cell Immunol; 1981 Jul; 62(1):101-9. PubMed ID: 7261067
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Parant M; Parant F; Chedid L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3395-9. PubMed ID: 356054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. beta 1H stimulates mouse-spleen B lymphocytes as demonstrated by increased thymidine incorporation and formation of B cell blasts.
    Hammann KP; Raile A; Schmitt M; Mussel HH; Peters H; Scheiner O; Dierich MP
    Immunobiology; 1981; 160(3-4):289-301. PubMed ID: 6459990
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706
    [No Abstract]   [Full Text] [Related]  

  • 46. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
    Taniyama T; Holden HT
    Cell Immunol; 1979 Dec; 48(2):369-74. PubMed ID: 228871
    [No Abstract]   [Full Text] [Related]  

  • 47. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

  • 48. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
    Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitogenic activity of adjuvant-active N-acetylmuramyl-L-alanyl-D-isoglutamine and its analogues.
    Takada H; Kotani S; Kusumoto S; Tarumi Y; Ikenaka K
    Biken J; 1977 Jun; 20(2):81-5. PubMed ID: 563229
    [No Abstract]   [Full Text] [Related]  

  • 50. The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes.
    Altman A; Cardenas JM; Bechtold TE; Katz DH
    J Immunol; 1980 Jan; 124(1):114-20. PubMed ID: 6153087
    [No Abstract]   [Full Text] [Related]  

  • 51. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the mechanism of early recovery of specifically depleted lymphoid cell populations by nonspecific activation of T cells.
    Prunet J; Birrien JL; Panijel J; Liacopoulos P
    Cell Immunol; 1978 Apr; 37(1):151-61. PubMed ID: 306882
    [No Abstract]   [Full Text] [Related]  

  • 53. Strain variations in murine MIF production.
    Adelman N; Cohen S; Yoshida T
    J Immunol; 1978 Jul; 121(1):209-12. PubMed ID: 353191
    [No Abstract]   [Full Text] [Related]  

  • 54. [Increase of non-specific resistance to infection by synthetic adjuvants].
    Parant M; Chedid L
    C R Seances Soc Biol Fil; 1979; 173(2):201-12. PubMed ID: 159749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
    Iribe H; Koga T; Onoue K; Kotani S; Kusumoto S; Shiba T
    Cell Immunol; 1981 Oct; 64(1):73-83. PubMed ID: 7028277
    [No Abstract]   [Full Text] [Related]  

  • 56. Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. II. Relationship between adjuvant activity and stimulation of DNA synthesis by polyanions.
    Vogt W; Rühl H; Wagner B; Diamantstein T
    Eur J Immunol; 1973 Aug; 3(8):493-6. PubMed ID: 4585313
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
    Löwy I; Leclerc C; Chedid L
    Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoadjuvant activity of pyran copolymer. I. Evidence for direct stimulation of T-lymphocytes and macrophages.
    Baird LG; Kaplan AM
    Cell Immunol; 1975 Dec; 20(2):167-76. PubMed ID: 1106874
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunomodulatory properties of a strain of Mycobacterium chelonae. I. Mouse lymphocyte responses in vitro.
    Neway T; Barrat F; Person JM; Boulouis HJ; Pilet C
    Comp Immunol Microbiol Infect Dis; 1989; 12(3):63-70. PubMed ID: 2582740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemia.
    Simon JD; Freed BM; Davignon D; Albala MM
    Cell Immunol; 1983 Nov; 82(1):163-73. PubMed ID: 6605807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.